Search Results - "Shaverdian N"

Exploratory Analysis of ctDNA and Imaging Response in the Phase I/II CHORUS Study of Canakinumab with Chemoradiation and Durvalumab Consolidation for Stage III NSCLC.

Authors: Shaverdian, N. Offin, M. Charalambous, K. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2024 Supplement, Vol. 120 Issue 2, pS86-S87. 2p.

Subjects: Circulating tumor DNA, Cell-free DNA, Image analysis, Preventive medicine, Chemoradiotherapy

Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors.

Authors: Shaverdian, N. Beattie, J. Thor, M. et al.

Source: Annals of Oncology. Dec2020, Vol. 31 Issue 12, p1719-1724. 6p.

Tumor Mutational Burden Predicts Progression-Free Survival and Local-Regional Control in Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Durvalumab.

Authors: Shaverdian, N. Shepherd, A.F. Offin, M. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2022 Supplement, Vol. 114 Issue 3, pe390-e391. 2p.

Subjects: DNA repair, Non-small-cell lung carcinoma, Progression-free survival, Cancer patients, Chemoradiotherapy, Fanconi's anemia

Effects of Liver Metastases and Liver-Metastasis-Directed Radiotherapy on Response to Immunotherapy.

Authors: Yu, Y. Shaverdian, N. Barker, C.A. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2021 Supplement, Vol. 111 Issue 3, pe472-e473. 2p.

Subjects: Bladder cancer, Anal cancer, Liver metastasis, Non-small-cell lung carcinoma, Immune checkpoint proteins, Colorectal cancer, Overall survival

The Patient's Perspective on Chemoradiation for Anal Cancer: Evaluation of Expectations and Stigma.

Authors: Chang, E.M. Shaverdian, N. Lee, P. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2019 Supplement, Vol. 105, pE592-E593. 2p.

Subjects: Social stigma, Chemoradiotherapy

Cost-Effectiveness Analysis of External Beam Radiation Therapy Versus Cryoablation for Palliation of Uncomplicated Bone Metastases.

Authors: Chang, E.M. Shaverdian, N. Capiro, N. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2018 Supplement, Vol. 102, pS159-S160. 2p.

Impact of Electronic Access to Physician Notes on Oncology Patients: A Prospective Evaluation.

Authors: Shaverdian, N. Chang, E.M. Morasso, E.G. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2018 Supplement, Vol. 102, pe732-e733. 2p.

The Effect of SBRT Treatment Duration for Early Stage NSCLC on Control Rates, Survival and Toxicity.

Authors: van Dams, R. Shaverdian, N. Raghavan, G. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2018 Supplement, Vol. 102, pe710-e711. 2p.

Comparing Outcomes of Patients with Early Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy Based on Frailty Status.

Authors: Raghavan, G. Shaverdian, N. Chan, S. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2018 Supplement, Vol. 102, pe701-e702. 2p.

Exploring Associations between Immune Parameters and Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer after Chemoradiation and Durvalumab.

Authors: Thor, M. Shaverdian, N. Shepherd, A.F. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pe114-e114. 1p.

Subjects: Non-small-cell lung carcinoma, Chemoradiotherapy

One-Year Disease Outcomes in Stage III Non-Small Cell Lung Cancers Treated with Trimodality Therapy vs Concurrent Chemoradiation and Durvalumab.

Authors: Shaverdian, N. Shepherd, A.F. Offin, M. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pe113-e113. 1p.

Subjects: Non-small-cell lung carcinoma, Disease progression, Pneumonectomy, Chemoradiotherapy

Real-World Evaluation of Consolidative Durvalumab in Locally Advanced Non-Small-Cell Lung Cancer Treated with Definitive Chemoradiation.

Authors: Shaverdian, N. Zhang, Z. Lobaugh, S. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2019 Supplement, Vol. 105, pE531-E531. 1p.

Subjects: Non-small-cell lung carcinoma, Chemoradiotherapy

The Patient's Perspective on Radiation for Rectal Cancer: Initial Expectations Versus Actual Experience.

Authors: Chang, E.M. Shaverdian, N. Lee, P. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2019 Supplement, Vol. 105, pE593-E593. 1p.

Subjects: Rectal cancer, Radiation, Adjuvant treatment of cancer, Rotational motion, Abdominoperineal resection, Research grants

Impact of Cardiac Radiation Dosimetry on Overall Survival in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.

Authors: Chan, S. Shaverdian, N. Ruan, D. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2018 Supplement, Vol. 102, pS92-S92. 1p.

The Patient's Perspective on Breast Radiation Therapy: Initial Fears and Expectations Versus Reality.

Authors: Shaverdian, N. Wang, X. Hegde, J.V. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2017 Supplement, Vol. 99, pS39-S40. 1p.

Subjects: Radiotherapy, Breast cancer, Cancer chemotherapy

Impact of Prior Radiation Therapy on the Efficacy and Toxicity of Pembrolizumab in the Treatment of Non–small Cell Lung Cancer.

Authors: Shaverdian, N. Lisberg, A.E. Bornazyan, K. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2017 Supplement, Vol. 99, pS151-S151. 1p.

Subjects: Radiotherapy, Pembrolizumab, Non-small-cell lung carcinoma, Cancer treatment

Functional Outcomes after De-escalated Chemoradiation for Human Papillomavirus-Positive Oropharyngeal Cancer: Findings from a Phase 2 Trial.

Authors: Hegde, J.V. Shaverdian, N. Felix, C. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2017 Supplement, Vol. 99, pS42-S42. 1p.

Subjects: Pharyngeal cancer, Chemoradiotherapy, Health outcome assessment

Pretreatment Markers of Systemic Inflammation and Outcomes With Stereotactic Radiosurgery for Brain Metastases.

Authors: Shaverdian, N. Wang, J. Levin-Epstein, R. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2016 Supplement, Vol. 96, pE73-E73. 1p.

Subjects: Systemic inflammatory response syndrome, Stereotactic radiosurgery, Brain metastasis, Magnetic resonance imaging of cancer, Kaplan-Meier estimator, Multivariate analysis, Therapeutics

Clinical Validation and Implementation of the 5DCT Technique for Breathing-Gated Image Generation for Lung Cancer Treatment Planning.

Authors: O'Connell, D. Shaverdian, N. Kishan, A.U. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2016 Supplement, Vol. 96, pE687-E687. 1p.

Subjects: Lung cancer treatment, Cancer radiotherapy, Computed tomography, Radiotherapy treatment planning, Health outcome assessment

Pretreatment Anemia Portends Poor Outcomes in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.

Authors: Shaverdian, N. Veruttipong, D. Wang, J. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2016 Supplement, Vol. 96, pE427-E427. 1p.

Subjects: Stereotactic radiotherapy, Cancer treatment, Non-small-cell lung carcinoma, Anemia, Radiation dosimetry, Patients